Logo of Adverum Biotechnologies

Remote Jobs at Adverum Biotechnologies

Gene therapy for vision

Gene Therapy
Biotechnology
Rare Diseases
Ophthalmology
Retina

About Adverum Biotechnologies

Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company focused on establishing gene therapy as a new standard of care for prevalent ocular diseases. Utilizing its proprietary intravitreal (IVT) platform, Adverum develops durable, single-administration therapies to eliminate frequent ocular injections. The company is advancing ixoberogene soroparvovec (Ixo-vec) for neovascular age-related macular degeneration. Adverum aims to transform care, preserve vision, and make a global impact.

Established

2012

Company Size

51-200 employees